Inventor · disambiguated record
Eckhard Ottow
Also filed as: OTTOW ECKHARD
39 granted patents·642 citations·filing 1986–2004
98Inventor score
Top patents by PatentIndex Score
39 records- 0191US4814327A11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing sameSCHERING AG·Filed 1987·Granted Mar 21, 1989·49 cites·18 claims
- 0289US6818661B2Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitorsNOVARTIS AG·Filed 2001·Granted Nov 16, 2004·21 cites·5 claims
- 0386US7122547B1Anthranilic acid amides and the use thereof as medicamentsNOVARTIS AG·Filed 1999·Granted Oct 17, 2006·79 cites·14 claims
- 0484US5089488Aβ-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing sameSCHERING AG·Filed 1990·Granted Feb 18, 1992·44 cites·17 claims
- 0583US4829060A11 Beta-N,N-dimethylaminophenyl-estradienes, their manufacture and pharmaceutical preparations containing themSCHERING AG·Filed 1986·Granted May 9, 1989·32 cites·30 claims
- 0682US5095129A19,11 β-bridged steroids, their manufacture and pharmaceutical preparations containing themSCHERING AG·Filed 1988·Granted Mar 10, 1992·31 cites·27 claims
- 0781US5273971A13-alkyl-11β-phenylgonanesSCHERING AG·Filed 1989·Granted Dec 28, 1993·26 cites·9 claims
- 0880US6608074B2Contraception method using competitive progesterone antagonists and novel compounds useful thereinSCHERING AG·Filed 2001·Granted Aug 19, 2003·9 cites·11 claims
- 0979US5439913AContraception method using competitive progesterone antagonists and novel compounds useful thereinSCHERING AG·Filed 1992·Granted Aug 8, 1995·26 cites·17 claims
- 1079US4870069A11β-alkynyl-estrenes and -estradienes, their production and pharmaceutical preparations containing themSCHERING AG·Filed 1988·Granted Sep 26, 1989·27 cites·20 claims
- 1178US5244886A11β-phenyl-14βH steroidsSCHERING AG·Filed 1989·Granted Sep 14, 1993·27 cites·16 claims
- 1277US5446036A13-alkyl-11beta-phenylgonanesSCHERING AG·Filed 1993·Granted Aug 29, 1995·32 cites·10 claims
- 1374US5132299A11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing sameSCHERING AG·Filed 1988·Granted Jul 21, 1992·21 cites·11 claims
- 1472US6025376AChiral methylphenyloxazolidinonesSCHERING AG·Filed 1996·Granted Feb 15, 2000·32 cites·6 claims
- 1572US5843933A11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agentsSCHERING AG·Filed 1995·Granted Dec 1, 1998·31 cites·34 claims
- 1671US6790853B2Contraception method using competitive progesterone antagonists and novel compounds useful thereinSCHERING AG·Filed 2003·Granted Sep 14, 2004·3 cites·14 claims
- 1769US6949655B2Acyclic piperidine derivativesLAUFFER DAVID·Filed 2002·Granted Sep 27, 2005·5 cites·7 claims
- 1868US5093507A10β,11β-bridged steroidsSCHERING AG·Filed 1989·Granted Mar 3, 1992·15 cites·25 claims
- 1967US5426102A14β-H-, 14-and 15-En-11β-aryl-4-oestrenesSCHERING AG·Filed 1991·Granted Jun 20, 1995·20 cites·3 claims
- 2066US5843931A6,7-modified 11β-aryl-4-oestrenesSCHERING AG·Filed 1991·Granted Dec 1, 1998·21 cites·4 claims
- 2163US5728689A11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agentsSCHERING AG·Filed 1995·Granted Mar 17, 1998·18 cites·26 claims
- 2262US5405979AProcess for the production of 10β-H-steroidsSCHERING AG·Filed 1991·Granted Apr 11, 1995·15 cites·5 claims
- 2361US5232915A9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroidsSCHERING AG·Filed 1990·Granted Aug 3, 1993·14 cites·10 claims
- 2460US7297702B2Contraception method using competitive progesterone antagonists and novel compounds useful thereinSCHERING AG·Filed 2004·Granted Nov 20, 2007·0 cites·11 claims
- 2556US7321044B2Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogensSCHERING AG·Filed 2002·Granted Jan 22, 2008·2 cites·34 claims
- 2653US7479491B2Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitorsNOVARTIS AG·Filed 2004·Granted Jan 20, 2009·0 cites·3 claims
- 2753US5446178AProcess for preparing 19,11β-bridged steroidsSCHERING AG·Filed 1993·Granted Aug 29, 1995·9 cites·35 claims
- 2850US6340688B1Contraception method using competitive progesterone antagonists and novel compounds useful thereinSCHERING AG·Filed 1998·Granted Jan 22, 2002·5 cites·12 claims
- 2949US6284779B1Heteroaromatic compoundsSCHERING AKTIIENGESELLSCHAFT·Filed 2000·Granted Sep 4, 2001·1 cites·20 claims
- 3047US7659364B2N-methyl-homocysteines and their use as well as process for their productionCIS BIO INT·Filed 2002·Granted Feb 9, 2010·1 cites·17 claims
- 3146US6143733AQuinoxalinedione derivatives, their production and use in pharmaceutical agentsSCHERING AG·Filed 1995·Granted Nov 7, 2000·7 cites·4 claims
- 3243US5523298AProgestationally active 19,11-bridged 4-estrenesSCHERING AG·Filed 1993·Granted Jun 4, 1996·4 cites·10 claims
- 3343US5519027AD-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agentsSCHERING AG·Filed 1991·Granted May 21, 1996·5 cites·7 claims
- 3439US5359054AInitial compounds for the production of 10β-H-steroids and a process for the production of these initial compoundsSCHERING AG·Filed 1991·Granted Oct 25, 1994·4 cites·3 claims
- 3535US5703066AProgestationally active 19,11-bridged 4-estrenesSCHERING AG·Filed 1995·Granted Dec 30, 1997·1 cites·13 claims
- 3633US6136805AQuinoxaline dione derivatives, their production and their use in medicamentsSCNERING AG·Filed 1996·Granted Oct 24, 2000·3 cites·8 claims
- 3730US6596713B1Steroid esters and amides, process for their production and their pharmaceutical useSCHERING AG·Filed 1997·Granted Jul 22, 2003·2 cites·21 claims
- 3830US6096732ASteroid esters, process for their production and their pharmaceutical useSCHERING AG·Filed 1997·Granted Aug 1, 2000·0 cites·24 claims
- 3928US6127368AAnellated β-carbolinesSCHERING AG·Filed 1996·Granted Oct 3, 2000·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →